SCHEMBL5670780

SCHEMBL5670780

CCN(C(=O)OC(C)(C)C)c1ccccc1Nc1ccccc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 2/20 0.41
L3MBTL1 Q9Y468 4/20 0.40
MAPT P10636 3/20 0.40
MAPK1 P28482 3/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MCL1 Q07820 1/20 0.40
ATM Q13315 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
GAA P10253 2/20 0.39
HTT P42858 1/20 0.39
ALOX12 P18054 1/20 0.39
POLB P06746 2/20 0.39
ITGA4 P13612 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5671832 0.83 AKR1C3 (0.48) LMNAAKR1C3AKR1C2L3MBTL1MAPT
SCHEMBL28261500 0.77 TSHR (0.41) LMNAL3MBTL1MAPTKDM4EALDH1A1
SCHEMBL12117477 0.74 CYP3A4 (0.54) LMNAL3MBTL1MAPTKDM4EALDH1A1
SCHEMBL30443001 0.74 CYP3A4 (0.54) LMNAL3MBTL1MAPTKDM4EALDH1A1
SCHEMBL17077864 0.74 TSHR (0.39) LMNAL3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL17846074 0.73 TDP1 (0.40) LMNAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL16113033 0.73 ALDH1A1 (0.38) LMNAL3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL4841484 0.73 KMT2A (0.43) LMNAMAPTSMN1; SMN2HTTPOLB
SCHEMBL7375645 0.72 TSHR (0.37) LMNAL3MBTL1MAPTKDM4EALDH1A1
SCHEMBL729160 0.72 ITGA4 (0.40) MAPTSMN1; SMN2PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660467-A2 AMINOFURAZAN COMPOUNDS AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2006-05-31 EP disclosed
WO-2005019190-A2 (4 -AMINO -1,2, 5-OXADIAZOL-4-YL) -HETΞROAROMATIC COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-03-03 WO disclosed